Radiology:Fabry病不良心脏事件的心脏MRI预测评价

2020-06-10 shaosai MedSci原创

Fabry病心脏受累是患者主要的死亡原因。对于预测不良心脏事件的影像学表现的识别有助于识别高风险患者。

背景

Fabry病心脏受累是患者主要的死亡原因。对于预测不良心脏事件的影像学表现的识别有助于识别高风险患者。

目的

本研究旨在评价心脏MRI影像学表现在预测Fabry病患者的预测价值。

材料与方法

本研究纳入了男性和女性Fabry病基因阳性的患者,并行心脏MRI。心脏MRI评价人员对临床信息采用盲法进行评价影像学征象。评价不良心脏事件作为综合截点,主要包括室性心动过速、心动过缓且需心脏起搏器植入和心源性死亡。统计学分析包括Cox比例危害模型、Mainz严重性评分系统(一种评价Fabry病严重性的指标)。

结果

本研究共纳入了90例患者进行评价。随访中位数时间为3.6年。出现综合节点的患者共有21人(每年发生率约为7.6%)。左心室肥厚(LVH)和延迟钆剂增强(LGE)是预测综合节点的独立预测指标(LVH HR, 3.0; 95% CI: 1.1, 8.1; P = .03; LGE HR, 7.2; 95% CI: 1.5, 34; P = .01)。具有广泛LGE(≥15%左心室体积)的患者具有最高的风险risk (HR, 12; 95% CI: 2.0, 67; P = .006)。性别对综合节点-心脏MRI征象间关系并无影响。

结论

心脏MRI征象包括左心室肥厚和延迟钆剂强化可用于识别不良心脏事件高风险的患者。

原始出处:Hanneman K, Karur GR, Wasim S.et al. Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease.DOI:10.1148/radiol.2019191385

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2036995, encodeId=d1b12036995d3, content=<a href='/topic/show?id=cf6d51401d9' target=_blank style='color:#2F92EE;'>#心脏事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51401, encryptionId=cf6d51401d9, topicName=心脏事件)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Thu Dec 03 14:54:05 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785954, encodeId=3fd31e8595419, content=<a href='/topic/show?id=f61fe20776' target=_blank style='color:#2F92EE;'>#Fabry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7207, encryptionId=f61fe20776, topicName=Fabry)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Aug 21 05:54:05 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424087, encodeId=c6be142408e86, content=<a href='/topic/show?id=ffa151395d8' target=_blank style='color:#2F92EE;'>#心脏MRI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51395, encryptionId=ffa151395d8, topicName=心脏MRI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c583898718, createdName=xfpan13, createdTime=Fri Jun 12 02:54:05 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444631, encodeId=d7bf1444631a3, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Jun 12 02:54:05 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2036995, encodeId=d1b12036995d3, content=<a href='/topic/show?id=cf6d51401d9' target=_blank style='color:#2F92EE;'>#心脏事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51401, encryptionId=cf6d51401d9, topicName=心脏事件)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Thu Dec 03 14:54:05 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785954, encodeId=3fd31e8595419, content=<a href='/topic/show?id=f61fe20776' target=_blank style='color:#2F92EE;'>#Fabry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7207, encryptionId=f61fe20776, topicName=Fabry)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Aug 21 05:54:05 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424087, encodeId=c6be142408e86, content=<a href='/topic/show?id=ffa151395d8' target=_blank style='color:#2F92EE;'>#心脏MRI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51395, encryptionId=ffa151395d8, topicName=心脏MRI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c583898718, createdName=xfpan13, createdTime=Fri Jun 12 02:54:05 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444631, encodeId=d7bf1444631a3, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Jun 12 02:54:05 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-08-21 仁医06
  3. [GetPortalCommentsPageByObjectIdResponse(id=2036995, encodeId=d1b12036995d3, content=<a href='/topic/show?id=cf6d51401d9' target=_blank style='color:#2F92EE;'>#心脏事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51401, encryptionId=cf6d51401d9, topicName=心脏事件)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Thu Dec 03 14:54:05 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785954, encodeId=3fd31e8595419, content=<a href='/topic/show?id=f61fe20776' target=_blank style='color:#2F92EE;'>#Fabry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7207, encryptionId=f61fe20776, topicName=Fabry)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Aug 21 05:54:05 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424087, encodeId=c6be142408e86, content=<a href='/topic/show?id=ffa151395d8' target=_blank style='color:#2F92EE;'>#心脏MRI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51395, encryptionId=ffa151395d8, topicName=心脏MRI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c583898718, createdName=xfpan13, createdTime=Fri Jun 12 02:54:05 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444631, encodeId=d7bf1444631a3, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Jun 12 02:54:05 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-06-12 xfpan13
  4. [GetPortalCommentsPageByObjectIdResponse(id=2036995, encodeId=d1b12036995d3, content=<a href='/topic/show?id=cf6d51401d9' target=_blank style='color:#2F92EE;'>#心脏事件#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51401, encryptionId=cf6d51401d9, topicName=心脏事件)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5494471, createdName=HNYYM, createdTime=Thu Dec 03 14:54:05 CST 2020, time=2020-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785954, encodeId=3fd31e8595419, content=<a href='/topic/show?id=f61fe20776' target=_blank style='color:#2F92EE;'>#Fabry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7207, encryptionId=f61fe20776, topicName=Fabry)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Fri Aug 21 05:54:05 CST 2020, time=2020-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424087, encodeId=c6be142408e86, content=<a href='/topic/show?id=ffa151395d8' target=_blank style='color:#2F92EE;'>#心脏MRI#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51395, encryptionId=ffa151395d8, topicName=心脏MRI)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c583898718, createdName=xfpan13, createdTime=Fri Jun 12 02:54:05 CST 2020, time=2020-06-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1444631, encodeId=d7bf1444631a3, content=<a href='/topic/show?id=3d9291459d1' target=_blank style='color:#2F92EE;'>#评价#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91459, encryptionId=3d9291459d1, topicName=评价)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1fee5134542, createdName=huagfeg, createdTime=Fri Jun 12 02:54:05 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-06-12 huagfeg

相关资讯

Hypertension:左心室肥厚和重塑以及认知功能障碍和痴呆症的风险!

总之,在基线时没有临床检测到的心血管疾病和痴呆症的多民族队列研究中,LV肥厚和向心性重构与痴呆症和认知障碍事件独立相关。

Hypertension:高血压前期进展为高血压的患者,左室肥厚风险更高

近期,研究人员对PAMELA (Pressioni Monitorate E Loro Associazioni)处登记人群进行横断面和纵向数据分析,以评估左心室质量指数(LVMI)正常的亚组人群中入组时高血压前期和左心室肥厚(LVH)的关系以及相关的新发左室肥厚风险。最终研究结果发表于Hypertension杂志。基线状态下,横断面分析共纳入1397例超声心动图参数可测的未治疗患者。纵向分析则纳

Hypertension: 左心室肥厚能否增加运动量?放心动吧!

左心室肥厚是高血压患者预后的重要预测因素。体力活动与较高的左心室质量具有相关性,但同时也降低心血管疾病的风险。近期,Hypertension杂志发表一项研究,旨在探讨两个具体问题,即确定高血压的存在是否改变体力活动与左心室质量的关系以及左心室肥厚能否改变体力活动与预后的有益关系。

JACC:左心室肥厚不会影响经导管主动脉瓣置换术后的1年临床结局

在接受TAVR的当代患者队列中,根据左心室质量指数和相对壁厚的术前LVH与1年随访的不良结局无关。

Eur Heart J:二甲双胍治疗无糖尿病冠心病患者左​​心室肥厚的疗效分析

由此可见,二甲双胍治疗显著降低LVMI、LVM、诊室收缩压、体重和氧化应激。虽然LVH是心血管(CV)结局的良好替代指标,但是需要大型CV结局试验来确切证明二甲双胍的心脏保护作用。

J Hypertens:肾动脉狭窄和左心室肥厚有啥关系?

该荟萃分析表明与高血压患者相比,RAS患者左心室肥厚的可能性增加,肾动脉血运重建对左心室结构具有有益的效应,是通过左心室重量指数显著降低来反映。